Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Insys Therapeutics Inc. (INSY)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
OrbiMed Advisors

Samuel Isaly

3,028,354 $30,526 -14% 0.36%
2.
Blue Mountain Capital

Andrew Feldstein And Stephen Siderow

28,145 $284 +534% 0%
3.
Millennium Management

Israel Englander

289,013 $2,913 +70% 0%
4.
D E Shaw

D. E. Shaw

198,180 $1,998 +320% 0%
5.
Springbok Capital

Gavin Saitowitz And Cisco J. Del Valle

486 $5 -22% 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$8.93 17,500 Large Shareholder 42,447,810 2017-08-11 Filing
$8.92 5,500 Officer, Director 15,400 2017-08-10 Filing
$11.10 5,400 Officer, Director 9,900 2017-06-14 Filing
$14.14 4,000 Director 4,000 2017-06-01 Filing
$12.21 8,000 Director 52,083 2017-05-18 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$6.41 166,504 Director 0 2018-05-10 Filing
$18.02 15,000 Director 2,000 2016-08-16 Filing
$18.46 15,000 Director 49,682 2016-08-11 Filing
$19.16 5,781 Officer 1 2016-08-09 Filing
$16.27 16,000 Director 2,000 2016-06-06 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 96,105 $969 0.07%
2. 61,600 $621 0.06%
3. 83,940 $846 0.03%
4. 159,133 $1,604 0.01%
5. 11,994 $107 0.01%
News See All